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by Snorri S. Thorgeirsson,*t Leonard C. Erickson,*
Carole L. Smith* and Irene B. Glowinski*
Coincubation of isolated, intact rat hepatocytes with Salmonella typhimurium tester strain TA 98
(Salmonella/hepatocyte system) has been employed to determine both bacterial mutagenicity and
DNA damage in the hepatocytes following treatment with 2-acetylaminofluorene (AAF) and other
AAF derivatives. In vivo pretreatment of rats with either 2,3,7,8,-tetrachlorodibenzo-p-dioxin
(TCDD) or 3-methylcholanthrene (MC) markedly increased both DNA damage and bacterial
mutation frequency upon incubation of AAF or 2-aminofluorene (AF), in this system. The increase in
damage to the hepatocyte-DNA was more pronounced after AAF treatment than by that for AF,
while the increase in bacterial mutation frequency was greater after AF treatment. Hepatocytes
treated with paraoxon prior to exposure to N-hydroxy-2-acetylaminofluorene (N-OH-AAF) or N-
acetoxy-2-acetylaminofluorene (N-OAc-AAF) partially inhibited the DNA damage caused by these
agents, as well as inhibiting the bacterial mutagenicity of N-OAc-AAF (50% inhibition) and N-OH-
AAF (80% inhibition). These data indicate that metabolic processes other than those involved in
activating AAF and its derivatives into a bacterial mutagen(s) may contribute to the genotoxic
effects of these compounds. Thus, the Salmonella/hepatocyte system may provide a useful model in
which to study the relative role of the various metabolic processes associated with the carcinogenic
effects ofN-acetylarylamines.
Introduction
Carcinogenic N-acetylarylamines, such as 2-ace-
tylaminofluorene (AAF), are extensively metabo-
lized in animals that are both resistant and
susceptible to the carcinogenic effects of these
compounds (1). In the organism, metabolic
processing of N-acetylarylamines involves both
detoxification and activation (toxification), and there
is convincing evidence that the ratio between these
two processes may, to a large extent, determine the
susceptibility to carcinogenesis from these com-
pounds (2, 3).
Recent studies on the mechanism of AAF-induced
hepatocarcinogenesis have clearly established that
the oncogenic process proceeds via initiation and
promotion phases (4). AAF is a complete rat liver
carcinogen that can provoke initiation as well as
maintain the promotional aspects of the carcino-
genic process in this species. It thus seems reason-
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able to ask which of the metabolic pathways in-
volved in AAF metabolism can convert this com-
pound into derivatives that are responsible for
these two phases of AAF-induced carcinogenesis.
This is of particular interest with respect to AAF as
the obligatory N-hydroxylation step is followed by
several activation pathways (Fig. 1).
Previous work from our laboratory indicated that
deacetylation, either by membrane bound deacety-
lase(s) or by cytosolic N-O-acyltransferase, was the
most important step in the mutagenic activation of
N-hydroxy-2-acetylaminofluorene (N-OH-AAF) in the
Salmonella system (5). One drawback to the use of
subcellular fractions such as S-9 and microsomes in
these metabolic activation experiments is the lack
of metabolic detoxification processes that can occur
in the intact organism. Therefore the balance be-
tween metabolic activation and detoxification that
ultimately determines the toxic effects in vivo is not
reflected. In order to correct this imbalance we
have recently devised a system employing intact
rat hepatocytes (or any other cell type) in com-
bination with Salmonella tester strains (Salmonella/-
hepatocyte system) to study the genotoxic effects of
known or suspected carcinogens (6). In this systemTHORGEIRSSON ETAL.
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FIGURE 1. Metabolic pathways for 2-acetylaminofluorene. CB indicates covalent binding.
both the mutation frequency in the bacteria and the
genotoxic effect in the hepatocyte are measured af-
ter carcinogen treatment. The resultant DNA dam-
age, determined by alkaline elution (7, 8), therefore
reflects the net effect of all metabolic activation and
detoxification processes of which the cell is capable.
This paper describes results obtained using the Sal-
monella/hepatocyte system to study the metabolic
activation of AAF, N-OH-AAF, 2-aminofluorene
(AF), and N-acetoxy-2-acetylaminofluorene (N-OAc-
AAF).
Materials and Methods
AAF, MC and AF were obtained from Eastman
Organic Chemicals Co. (Rochester, NY); N-OH-AAF
and N-OAc-AAF were obtained from Dr. E. Weis-
burger and Dr. D. Longfellow, respectively, both at
the National Cancer Institute; 2,3,7,8-tetrachlorodi-
benzo-p-dioxin (TCDD) was obtained from Dow
Chemical Co., Midland, MI; collagenase (C65II, 136
units/mg) was purchased from Worthington Bio-
chemical Corp. (Freehold, NJ); Salmonella tester
strain TA 98 was supplied by Dr. Bruce N. Ames,
University of California, Berkeley. Male Sprague-
Dawley rats (180-200 g) were provided by the Na-
tional Institutes of Health Animal Supply. Isolation
of hepatocytes, mutagenesis assays and alkaline
elution of DNA were performed as previously
described (6). Induction was achieved by injecting
either 80 mg/kg MC IP or 50 M.g/kg TCDD IP, 48 hr
prior to isolation of hepatocytes.
Results and Discussion
Pretreatment of rats and mice with polycyclic ar-
omatic hydrocarbons such as MC is known greatly
to increase the rate of microsomal N-hydroxylation
of AAF and other N-acetylarylamines (2). Similarly,
pretreatment with TCDD induces a 40-fold increase
in N-hydroxylation of AAF in isolated rat hepato-
cytes (9). As N-hydroxylation appears to be the rate-
limiting step in the mutagenic activation of AAF (5,
10), the effect of TCDD and/or MC pretreatments
upon both the genotoxicity and mutagenicity of AF
or AAF in the Salmonella/hepatocyte system has
been examined Figs. 2 and 3). After pretreatment
with TCDD, DNA damage in the hepatocytes is
increased in a dose-dependent fashion following
exposure to AF or AAF (Fig. 2). However, the
increase in alkaline labile sites is much more
pronounced after AAF exposure than after ex-
posure to AF. In contrast, when mutation frequency
in TA 98 is determined under the same conditions,
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FIGURE 2. Effects of TCDD induction on DNA damage by AF and AAF in the Salmonella/hepatocyte system. Rats were treated
with 50Mg/kg IP of TCDD 48 hr prior to isolation of hepatocytes.
the increase in mutagenicity is much greater for AF
than it is for AAF (Fig. 3). It is possible that a single
metabolite of AF and/or AAF is responsible for bac-
terial mutation, while DNA damage in the hepato-
cyte, as measured by alkaline elution, may result
from the additive effect of more than one reactive
metabolite.
Previous work has shown that N-hydroxy-2-ami-
nofluorene (N-OH-AF) is the mutagenic species de-
rived from N-OH-AAF in the Salmonella system (5).
N-OH-AF is a direct frameshift mutagen in tester
strain TA 98 as first shown by Ames et al. (11, 12).
Therefore it is reasonable to assume that N-OH-AF
is the bacterial mutagen derived from both AF and
AAF in the Salmonella/hepatocyte system. How-
ever, other reactive metabolites derived from AAF
such as the sulfate ester of N-OH-AAF or N-acet-
oxy-AF (see Fig. 1) may contribute to the DNA dam-
age either by direct interaction with DNA, or by
causing general cytotoxic effects. As a result, cellu-
lar DNA may become sensitive to the alkaline con-
dition employed.
Paraoxon (diethyl-p-nitrophenyl phosphate) is an
effective inhibitor of the microsomal deacetylase re-
sponsible for activation of N-OH-AAF to a frame-
shift mutagen (i.e, N-OH-AF) (12). However it does
not inhibit the mutagenic activation of N-OH-AAF
by the cytosolic N-O-acyltransferase (14). The use of
this inhibitor thus provides an important tool in
evaluating the relative importance of deacetylation
and N-O-acyltransfer in the metabolic activation of
N-OH-AAF. Figures 4 and 5 show that in vitro pre-
treatment of isolated hepatocytes with paraoxon is
capable of partially inhibiting the DNA damage
caused by both N-OH-AAF and N-OAc-AAF. This
indicates that metabolic processes in addition to
paraoxon-sensitive deacetylation contribute to N-
OH-AAF-and/or N-OAc-AAF-induced DNA damage
in normal rat hepatocytes. The mutation frequency
caused by both N-OH-AAF and N-OAc-AAF in
strain TA 98 is also inhibited by paraoxon (Figs. 6
and 7). The inhibition of mutagenicity is more pro-
nounced for N-OH-AAF (80-90% inhibition) than for
N-OAc-AAF (<50%). However, the inhibition of N-
OH-AAF and N-OAc-AAF mutagenicity observed at
lower paraoxon concentrations (<106 M) disappears
at the highest concentration of paraoxon used
(104M). The reason for this effect of paraoxon at the
highest concentration is presently unclear. It is pos-
sible that the inhibitory effects of paraoxon are not
limited to the deacetylase at the higher concentra-
tions employed here.
Characterization of metabolic processes that are
critically involved in the activation and detoxifica-
tion of chemical carcinogens must be considered be-
fore any attempt to define the carcinogenic process
is undertaken. Use of intact cells from in vivo target
organ(s) for a particular chemical carcinogen pro-
143THORGEIRSSONETAL.
20
0
z
LL C
o
U--.-
z .n
I- 10
H:
30 60 90 120
TIME OF INCUBATION (min)
FIGURE 3. Effect of MC induction on mutagenicity of AF and
AAF in the Salmonella/hepatocyte system. Rats were
treated with 80 mg/kg IP of MC 48 hr prior to isolation of
hepatocytes. Concentration of both AAF and AF was 250
M: tester strain TA 98 was used.
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FIGURE 4. Inhibition of N-OH-AAF induced DNA damage by
paraoxon. Paraoxon was added to the hepatocytes 15 min
prior to the 30 min incubation with N-OH-AAF.
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FIGURE 5. Inhibition of N-OAc-AAF induced DNA damage
by paraoxon. Experimental conditions as described in leg-
end for Figure 4.
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FIGURE 6. Effect of paraoxon on N-OH-AAF mutagenicity in
the Salmonella/hepatocyte system. Paraoxon was added to
the hepatocytes 15 min prior to the addition of bacteria
and N-OH-AAF (100 PM). The complete system was incu-
bated for 30 min.
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FIGURE 7. Effect of paraoxon on N-OAc-AAF mutagenicity
in the Salmonella/hepatocyte system. Experimental condi-
tions as described in legend to Figure 6, except that the
concentration of N-OAc-AAF was 50 WM.
vides a way to study in a comprehensive fashion the
metabolic processes involved in carcinogenesis.
Therefore the Salmonella/hepatocyte system may
provide an important new model for studying the
relative roles of different metabolic pathways in the
initiation and promotion of hepatocarcinogenesis by
N-acetylarylamines.
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